A. Isla

发表

Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs

A. Beloqui, A. Pozo-Rodríguez, A. Isla, 2017 .

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

A. Isla, A. Rodríguez-Gascón, M. Solinís, 2022, Journal of Intensive Care.

Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

I. Trocóniz, J. Pedraz, A. Isla, 2008, Clinical pharmacokinetics.

Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria.

A. Canut, A. Rodríguez Gascón, A. Isla, 2012, International journal of antimicrobial agents.

Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain.

I. Trocóniz, J. Pedraz, A. R. Gascón, 2011, Enfermedades infecciosas y microbiologia clinica.

The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials

A. Isla, A. Rodríguez-Gascón, M. Solinís, 2021, Pharmaceutics.

Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation

A. Isla, A. Rodríguez-Gascón, Helena Barrasa, 2020, Pharmaceutics.

Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment

A. Canut, A. Isla, A. Rodríguez-Gascón, 2019, Journal of critical care.

Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens.

I. Trocóniz, A. Isla, A. Rodríguez-Gascón, 2015, International journal of antimicrobial agents.

Meropenem dosing requirements against Enterobacteriaceae in critically ill patients: influence of renal function, geographical area and presence of extended-spectrum β-lactamases

J. Arribas, A. Canut, A. Isla, 2016, European Journal of Clinical Microbiology & Infectious Diseases.

Pharmacokinetic–pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries

A. R. Gascón, A. Canut, A. Isla, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.

A. R. Gascón, J. L. Pedraz Muñoz, A. Isla, 2005, Clinical therapeutics.

Impact of augmented renal clearance (ARC) on the pharmacokinetics of linezolid: Advantages of continuous infusion from a PK/PD perspective.

A. Isla, A. Rodríguez-Gascón, Helena Barrasa, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

In vitro AN69 and Polysulphone Membrane Permeability to Ceftazidime and in vivo Pharmacokinetics during Continuous Renal Replacement Therapies

J. Pedraz, A. R. Gascón, A. Isla, 2007, Chemotherapy.

Meropenem and Continuous Renal Replacement Therapy: In Vitro Permeability of 2 Continuous Renal Replacement Therapy Membranes and Influence of Patient Renal Function on the Pharmacokinetics in Critically Ill Patients

J. Pedraz, A. R. Gascón, A. Isla, 2005, Journal of clinical pharmacology.

Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.

J. Pedraz, A. R. Gascón, A. Isla, 2005, Clinical therapeutics.

Influence of Renal Function on the Pharmacokinetics of Piperacillin/Tazobactam in Intensive Care Unit Patients During Continuous Venovenous Hemofiltration

J. Rello, J. Pedraz, A. R. Gascón, 2005, Journal of clinical pharmacology.

Augmented Renal Clearance in Critically Ill Patients: A Systematic Review

A. Isla, A. Rodríguez-Gascón, M. Solinís, 2018, Clinical Pharmacokinetics.

Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC.

J. Pedraz, A. R. Gascón, A. Isla, 2005, Journal of pharmaceutical and biomedical analysis.

Elimination of Piperacillin and Tazobactam by Renal Replacement Therapies with AN69 and Polysulfone Hemofilters: Evaluation of the Sieving Coefficient

J. Pedraz, A. R. Gascón, A. Isla, 2006, Blood Purification.

Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents.

Alicia Rodríguez-Gascón, Eduardo Asín-Prieto, Arantxazu Isla, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Vaginal gene therapy.

A. Isla, A. Rodríguez-Gascón, M. Solinís, 2015, Advanced drug delivery reviews.

Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.

J. Pedraz, A. R. Gascón, A. Isla, 2005, Biomedical chromatography : BMC.

Evaluation of Antimicrobial Treatments in Children with Acute Otitis Media in Spain: A Pharmacokinetic-Pharmacodynamic (PK/PD) Approach

J. Pedraz, A. Canut, C. García-rey, 2005, Journal of chemotherapy.

Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery

I. Trocóniz, S. Vázquez, A. Canut, 2012, European Journal of Clinical Pharmacology.

Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function.

A. Canut, A. Isla, A. Rodríguez-Gascón, 2015, International journal of antimicrobial agents.

Pharmacokinetic/pharmacodynamic evaluation of the antimicrobial therapy of pneumococcal invasive disease in adults in post-PCV13 vaccine period in Madrid, Spain

A. Canut, A. Isla, A. Rodríguez-Gascón, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies

A. Isla, A. Rodríguez-Gascón, M. Solinís, 2021, Pharmaceutics.

Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis.

I. Trocóniz, A. Isla, A. Rodríguez-Gascón, 2014, The Journal of antimicrobial chemotherapy.

Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery

I. Trocóniz, S. Vázquez, A. Canut, 2012, European Journal of Clinical Pharmacology.

Population pharmacokinetics of daptomycin in critically ill patients.

A. Isla, A. Rodríguez-Gascón, D. Soy, 2018, International journal of antimicrobial agents.

(Gene therapy: Novel therapeutic approach for treating ocular disorders)

A. Pozo-Rodríguez, A. Isla, M. Solinís, 2020 .

Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature

C. Aguirre, B. Calvo, A. Isla, 2017, European Journal of Clinical Pharmacology.

Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability

E. Suárez, V. Vozmediano, A. Isla, 2022, Antibiotics.

Meropenem dosing requirements against Enterobacteriaceae in critically ill patients: influence of renal function, geographical area and presence of extended-spectrum β-lactamases

J. Arribas, A. Canut, A. Isla, 2016, European Journal of Clinical Microbiology & Infectious Diseases.

Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution

A. Beloqui, A. Isla, A. Rodríguez-Gascón, 2014, Journal of Microencapsulation.

Medication errors in Parkinson's disease inpatients in the Basque Country.

A. Isla, M. Solinís, U. Lertxundi, 2017, Parkinsonism & related disorders.

Anticholinergic burden in Parkinson’s disease inpatients

A. Isla, M. Solinís, U. Lertxundi, 2015, European Journal of Clinical Pharmacology.

Pharmacokinetic–pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries

A. Canut, A. Isla, C. Betriú, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Pharmacotherapeutic management of Parkinson’s disease inpatients: how about asking hospital pharmacists?

A. Isla, M. Solinís, S. Domingo-Echaburu, 2020, European journal of hospital pharmacy : science and practice.

A Proposal to Prevent Omissions and Delays of Antiparkinsonian Drug Administration in Hospitals

A. Isla, M. Solinís, U. Lertxundi, 2015, The Neurohospitalist.

Impact of Acute Otitis Media Pathogen Shifts on the Clinical Efficacy of Several Antibiotics: A Therapeutic Outcomes Model

H. Maortua, A. Canut, A. Isla, 2009, Journal of chemotherapy.

Anticholinergic burden in Parkinson’s disease inpatients

A. Isla, M. Solinís, U. Lertxundi, 2015, European Journal of Clinical Pharmacology.